Chemotherapy in cancer patients often leads to thrombocytopenia that causes impaired therapeutic outcomes and threatens their survival. Studies show that about one out of ten cancer patients suffer from thrombocytopenia. Despite this rate, therapeutic options for chemotherapy-induced thrombocytopenia are limited due to severe adverse effects and high economic burdens. According to researchers from Fudan University, Shanghai, a ketogenic diet can boost the production of ketone bodies in the liver of both animals and humans, which in turn may reverse the chemotherapy-induced low platelet counts in the blood.
A ketogenic diet includes high-fat, high-protein, and very low- to no-carbohydrate nutritional therapies. Moreover, it can serve as a nontoxic, low-cost, and high-benefit addition to cancer therapy. A ketogenic diet was also found to induce circulating 3-β-hydroxybutyrate…
